. . "Being able to produce a large inventory of intestinal stem cells could be incredibly useful for stem cell therapy, where the cells could be delivered to patients to treat diseases such as Crohn's disease and ulcerative colitis, study co-senior author Jeffrey Karp, of the biomedical engineering division at Brigham and Women's Hospital, said in a hospital news release." . . .